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and treatment of Orthodontically induced
enamel White Spot Lesions (COS-OWSL)
Danchen Qin1,2, Yunlei Wang1,2, Colin Levey3, Peter Ngan4, Hong He1,2*, and Fang Hua2,5,6* on behalf of the
Core Outcome Set for trials on the prevention and treatment of enamel White Spot Lesions (COS-WSL) group
Abstract
Background: Enamel white spot lesions (WSLs), characterized by an opaque, matt, and chalky white appearance of
enamel, are a sign of incipient caries. WSLs are common in orthodontic practice and can affect both the oral health
and dental aesthetics of patients. Extensive studies have been conducted to evaluate the effectiveness of
prevention or treatment for orthodontically induced enamel WSLs. However, substantial heterogeneity has been
found in the outcomes used for the prevention and treatment of WSLs in literature, which prevents researchers
from comparing and combining the results of different studies to draw more decisive conclusions. Therefore, we
aim to develop a Core Outcome Set for trials on the prevention and treatment of Orthodontically induced enamel
White Spot Lesions (COS-OWSL).
Methods: The development of COS-OWSL comprises four phases: (1) a scoping review to identify and summarize
all existing outcomes that have been used in trials on the prevention or treatment of orthodontically induced WSLs;
(2) qualitative interviews with orthodontic patients without (for prevention) and with WSL-affected teeth (for
treatment) and relevant dental professionals to identify additional outcomes relevant to them; (3) Delphi surveys to
collect opinions from key stakeholders including patients, dental professionals, and researchers and to reach a
preliminary consensus; and (4) a consensus meeting to develop the final COS-OWSL.
Discussion: The COS-OWSL will be developed to facilitate the synthesis of evidence regarding the prevention and
treatment of orthodontically induced WSLs and to promote the consistent use of relevant patient-important
outcomes among future studies in this field.
Trial registration: Core Outcome Measures in Effectiveness Trials (COMET) initiative (the COS-WSL project) 1399
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Background
Dental caries is one of the most common oral diseases
and a significant cause of tooth loss [1]. Although pre-
ventable, dental caries still shows high prevalence, and
untreated dental caries poses a significant cost burden
on oral health services [2]. White spot lesions (WSLs)
are areas of demineralized enamel characterized by an
opaque, matt, and chalky white appearance without cavi-
tation [3, 4]. As a sign of incipient caries, WSLs can de-
velop into cavitated carious lesions if not treated timely
[5].
Poor oral hygiene is considered a major contributor to
WSLs [6, 7]. Orthodontic treatment is also an important
risk factor, and the incidence of WSLs is significantly
higher among orthodontic patients [8]. The appliances
used in orthodontic treatment such as brackets, bands,
and wires increase the number of plaque retention sites,
which add difficulties to the maintenance of good oral
hygiene [6, 9]. A recent review showed that the inci-
dence of WSLs in patients who received over 12-month
fixed orthodontic treatment was 23–76% [10]. In
addition, anterior teeth and premolars develop WSLs
more frequently, which can have a negative impact on
dental aesthetics [11]. Besides aesthetic concerns, the
demineralization can reduce the hardness of enamel and
leave it vulnerable to damage, therefore proceeding into
cavitation and reducing the lifetime prognosis of the
tooth [12].
Despite the high prevalence of orthodontically induced
WSLs, the methods used for detecting WSLs varied in
previous research [13]. Many tools can be used to detect
WSLs, including traditional visual inspection, photo-
graph and radiograph, transillumination, and fluores-
cence methods [14]. For example, direct visual
inspection, the simplest and most cost-effective detec-
tion method of WSLs, has been frequently adopted in
routine practice, but the specific approach and criteria
used in visual inspection are rarely consistent across dif-
ferent investigators and clinical settings [13, 15]. Quanti-
tative light-induced fluorescence evaluation is much
more sensitive than direct visual inspection and can de-
tect enamel demineralization before clinically visible [6],
but its relevance to patients may be limited.
The diversity of outcomes and outcome measures was
another issue in studies evaluating the effectiveness of
prevention or treatment of WSLs [16]. Some studies fo-
cused on the incidence or prevalence of WSLs to evalu-
ate the treatment effects [7, 11], while others utilized the
severity or activity of lesions [17]. Outcomes that re-
searchers used to assess the severity of WSLs include
colors [18], sizes or dimensions [19, 20], and surface
roughness [21] of lesions. In addition, investigators have
employed diverse outcome measures to assess the same
outcome [22]. For instance, more than ten scoring
criteria for visual inspection were used to classify WSLs
[13]. In a previous systematic review, four included stud-
ies that performed a direct visual examination for WSLs
utilized four different evaluation index systems [23]. The
lack of consistency among relevant assessment criteria
compromises the comparability of outcomes from clin-
ical trials and evidence synthesis.
Due to the aforementioned inconsistency in WSL
evaluation, researchers often fail to make effective com-
parisons between results from clinical trials [24]. Many
systematic reviews about WSLs found it impossible to
pool the results due to substantial heterogeneity [17,
25–29]. This prevents the improvement of health care in
this area and might pose the risk of continuing ineffect-
ive treatments to patients [24].
Extensive evidence has suggested that results from tri-
als and systematic reviews are often irrelevant to patients
and health service users. According to Fleming et al.
[30], only 22% of outcomes used in dental trials were
both patient and clinician centered. The use of patient-
reported outcomes may help dental professionals better
understand patient’s treatment need and improve oral
health care [31, 32]. However, a Cochrane systematic re-
view on fluorides for preventing WSLs during fixed
orthodontic treatment found that patient-reported out-
come was not included in any of the included trials [33].
Quantitative measurement for WSLs such as optical and
fluorescent methods is accurate and useful in research,
but it might not be cost-effective and meaningful to pa-
tients. Therefore, future research needs to increase the
relevance of results to both patients and dental
professionals.
To address issues outlined above, it is essential to de-
velop a core outcome set (COS) for trials on the preven-
tion and treatment of orthodontically induced enamel
WSLs. Core outcome sets are agreed standardized sets
of outcomes that should be measured and reported in all
clinical trials for a specific healthcare area [34]. Hence,
outcomes in a COS will always be included and reported
as a minimum, while researchers can explore and meas-
ure other outcomes of interest as well. If an outcome is
not included in a particular trial, researchers should de-
termine a priori and explain the reason [35].
At present, a COS for Outcomes in Trials for Manage-
ment of Caries Lesions (OuTMaC), designed for all
types of dental caries, is under development [36]. Al-
though orthodontically induced WSL is one type of den-
tal carious lesion, it tends to affect a narrower
population and has different levels of impact on aesthet-
ics and quality of life. In addition, due to its relatively
high prevalence in the anterior teeth, it may result in dif-
ferent outcomes of interest and affect the final COS.
The scope of OuTMaC is restricted to the management
of existing carious lesions and does not provide a COS
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for the prevention of dental caries. Therefore, the devel-
opment of COS-OWSL will facilitate outcome reporting
and evidence synthesis in trials on the prevention or
treatment of orthodontically induced WSLs.
Tsichlaki et al. [37] recently published a COS for
orthodontic treatment which included WSLs in its “ad-
verse effects and/or events” domain. However, with
“malocclusion” being its health condition and “ortho-
dontic treatment” being its intervention of interest, the
orthodontic COS was essentially developed for trials
evaluating the effectiveness of orthodontic therapies, and
therefore not adequate and applicable for trials on the
prevention and treatment of orthodontically induced
WSLs. Therefore, to address the existing outcome het-
erogeneity and facilitate future evidence synthesis in this
area, a specifically developed COS is needed. In addition,
as the COS for orthodontic treatment has determined
what should be measured [37], the next stage for our
profession is to determine how and when each outcome
should be measured. In this aspect, the development of a
COS for WSLs can provide support to future efforts re-
garding how “adverse effects and/or events” should be
measured.
Objectives
This article aims to present a protocol for the develop-
ment of a COS for trials on the prevention or treatment
of Orthodontically induced enamel White Spot Lesions
(COS-OWSL). In this study, we will develop a consensus
about “what” to measure for orthodontically induced
WSLs. “How” and “when” to measure will be determined
in future research. The objectives of this study are:
1. To identify all existing outcomes that have been
used in trials on the prevention or treatment of
orthodontically induced enamel WSLs by a scoping
review
2. To identify additional outcomes relevant to patients
and dental professionals by qualitative interviews
and to develop a list of candidate outcomes
3. To collect opinions from key stakeholders including
patients, dental professionals, and researchers and
to reach a preliminary agreement through online
Delphi surveys
4. To achieve a final consensus on COS-OWSL by a
consensus meeting
Scope
The scope of this COS-OWSL is:
 Health condition: orthodontically induced enamel
WSLs in primary or permanent teeth
 Target population: orthodontic patients without (for
prevention) and with orthodontically induced WSL-
affected teeth (for treatment), without any age, sex,
or dentition restrictions
 Intervention: all interventions to prevent or treat
orthodontically induced WSLs
 Settings: clinical trials, other types of clinical
research, and dental clinical practice
Methods
The COS-WSL project was registered on the Core Out-
come Measures in Effectiveness Trials initiative
(COMET) website (http://www.comet-initiative.org/
studies/details/1399) which includes ongoing and com-
pleted COS protocols and studies in various medical
fields, all of which are freely available to the public. The
present study protocol was written in accordance with
the Core Outcomes Set-STAndardised Protocol Items
(COS-STAP) [38] and the Core Outcome Measures in
Effectiveness Trials (COMET) Handbook [39].
The COS-OWSL will be developed through a four-
phase process: a scoping review for existing outcomes,
qualitative interviews, a two-round Delphi survey, and a
consensus meeting. Patients will be involved in the
qualitative interviews, Delphi survey, and consensus
meeting to provide their preferences and choice of out-
comes regarding orthodontically induced WSLs.
Phase 1: Scoping review
To determine what to measure and to identify the exist-
ing knowledge, we will conduct a scoping review of all
outcomes used in published clinical trials regarding the
prevention and treatment of orthodontically induced
WSLs and develop an inclusive list of the outcomes. The
methods and findings of this scoping review will be re-
ported in accordance with the PRISMA extension for
Scoping Reviews (PRISMA-ScR) [40].
In this review, we will search three databases: MEDL
INE (via PubMed), Embase, and the Cochrane Central
Register of Controlled Trials (CENTRAL). The dates of
coverage will be restricted to the most recent 10 years to
obtain an up-to-date pool of relevant outcomes [39]. We
will use both free-text and subject headings in our
search strategy, based on the following main concepts:
“tooth demineralization” OR “white spot lesion,” “ortho-
dontics,” and “randomized controlled trial” OR “con-
trolled clinical trial.” In addition to electronic searches,
we will hand search references cited in those identified
eligible studies and relevant systematic reviews. A search
of grey literature will not be performed in this scoping
review, as it is considered unlikely to provide new rele-
vant outcomes or significantly alter the final list of the
outcomes [41].
The inclusion criteria will be as follows: (1) study type,
randomized controlled trials (RCTs) and controlled clin-
ical trials (CCTs); (2) target population, orthodontic
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patients without (for prevention) and with orthodontic-
ally induced WSL-affected teeth (for treatment) with any
dentition and in any health condition from both genders
and all age groups; (3) intervention, an intervention for
preventing or treating WSLs should be implemented
and compared with another intervention or a placebo;
and (4) outcome, a minimum of one subjective or ob-
jective outcome measure should be clearly reported. No
restrictions on settings or follow-up periods will be
adopted. The exclusion criteria will be in vitro or in situ
studies, case reports, case series, observational studies,
studies reported in languages other than English, and
publications without available full texts.
Two authors will screen the identified records inde-
pendently and in duplicate, according to the abovemen-
tioned eligibility criteria. Titles and abstracts will be
screened first, and if they lack sufficient information to
make a judgment, the corresponding full texts will be
obtained and examined. From each included study, two
authors will extract verbatim the study characteristics
and outcomes used [39]. A pilot study will be conducted
to calibrate the authors and develop a template for data
extraction using 10% of all included studies (randomly
selected). Thereafter, two authors will extract data from
the rest of included studies independently and in dupli-
cate. Any discrepancy during screening and data extrac-
tion will be settled through discussion with the other
authors.
After data extraction, outcomes with similar defini-
tions but different terminology will be merged into a sin-
gle standard outcome. The outcomes of WSL prevention
and treatment will be listed separately. Then, two au-
thors will categorize these outcomes into outcome do-
mains. Any discrepancy in the outcome classification
will be discussed through group consensus among all
authors. Finally, a preliminary list of outcome domains
will be developed accordingly to provide information for
the following phases.
Phase 2: Qualitative interviews
After the scoping review for all the existing outcomes
for orthodontically induced WSLs, qualitative interviews
will be performed to identify and fill the evidence gaps
and to determine outcomes relevant to patients and den-
tal professionals. The purpose of the qualitative inter-
views is to understand the perspectives of patients and
dental professionals on orthodontically induced WSLs,
and to ensure that no important outcomes are over-
looked [39, 42].
Purposeful sampling will be used to recruit
information-rich participants for the qualitative inter-
views to include as diverse ranges of opinions from pa-
tients and dental professionals as possible [43]. The
recruitment of patients and dental professionals will be
conducted in China. We will recruit patients with differ-
ent ages, genders, occupations, types of WSL-affected
teeth (primary or permanent, anterior or posterior), se-
verity of WSLs, and experience of any intervention for
WSLs (prevention or treatment). Patients under 18 years
old will be allowed to express their opinions, and opin-
ions from their parents or carers who are familiar with
their condition will also be collected to form combined
opinions [44]. We will also recruit dental professionals
with different ages, genders, dental specialties, and level
of experience in the prevention or treatment of WSLs.
Semi-structured interview questions will be developed
to help ask all participants similar questions and will be
piloted with a small group of patients and dental profes-
sionals. A dentist and researcher will interview the pa-
tients and dental professionals through face-to-face
interviews or phone calls one by one. The researcher will
be familiarized with the questions and receive training in
interview skills prior to interviews. Data collection from
interviews will be ended until data saturation is reached,
which is defined as no generation of new themes and
outcomes. When no new themes or outcomes emerge,
we will continue to interview two more participants to
confirm the saturation of data [45, 46].
The content of the interviews will be transcribed and
analyzed. To protect respondents’ privacy, the interview
will be anonymized, and all the raw data will be stored
in one author’s computer and kept confidential. A con-
tent analysis will be conducted to identify outcomes or
outcome domains reported by patients and dental pro-
fessionals. Two authors will perform the coding proced-
ure for the content analysis independently and in
duplicate and then categorize the responses into the pre-
defined outcome domains, with any disagreement re-
solved through discussion with the other authors. Only
new outcomes or outcome domains that are suggested
by two or more participants will be included in the out-
come list [47].
Two authors will combine the outcomes from the
qualitative interviews with the outcomes identified from
the scoping review and develop a list of outcomes rele-
vant to researchers, patients, and dental professionals for
the following consensus process.
Phase 3: Delphi survey
The online Delphi survey will consist of two-round an-
onymous questionnaires to specify which outcomes the
key stakeholders consider most important and to reach a
preliminary consensus among them.
Purposeful sampling strategies will be adopted to re-
cruit a diverse, international participant pool for the Del-
phi survey, with involvement from three stakeholder
groups: patients, dental professionals, and researchers
[48]. We will send potential participants a personalized
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email to explain the objectives of the survey and invite
them to participate. To minimize attrition, the import-
ance of their completion of the whole 2-round Delphi
process will be emphasized, and individuals who agree
to complete both rounds of the survey will be included.
Before the survey, we will send emails to ask participants
to opt in. Then, we will provide a link to the Delphi sur-
vey and the contact information of investigators to the
participants who agree to participate by email. Partici-
pants who do not complete the questionnaire in round 1
will not be invited for round 2. In both rounds of the
survey, email reminders will be sent every 2 weeks to
participants who have not finished the survey to
maximize completion rate. Each round of the survey will
last for a month; if the response rate of round 2 is low,
we will keep the survey open for another 2 weeks and
send additional reminders to minimize potential attrition
bias [39].
Both medical terms and plain language descriptions
will be provided in the questionnaire to avoid ambiguity
[48]. The outcomes will be voted for prevention and
treatment separately and presented by outcome do-
mains. Outcome domains and outcomes within each do-
main will be presented in a random order. Prior to the
official release, the full text of the questionnaire will be
piloted with several representatives from each stake-
holder group to refine the language and increase read-
ability for all stakeholders.
In round 1 of the Delphi survey, participants will be
provided with the list of outcome domains with candi-
date outcomes to decide which outcomes are most im-
portant. The importance of each candidate outcome will
be rated on a 1 to 9 scale recommended by the GRADE
group, in which 1 to 3 represents that an outcome is of
limited importance, 4 to 6 important but not critical,
and 7 to 9 critical [49]. At the end of the round 1 survey,
the participants will also be asked to list outcomes that
they consider relevant but not included in the question-
naire. For the existing outcomes, the participants will
also be allowed to make suggestions to improve the clar-
ity of the wording. We will revise the relevant wording
of the terms and definitions accordingly for the subse-
quent round.
The responses from round 1 will be summarized by
calculating the percentage of participants scoring each
score from 1 to 9 by stakeholder groups. Suggestions for
new outcomes in the first round Delphi survey will be
reviewed by two researchers independently and in dupli-
cate. For responses that are unclear or ambiguous, we
will ask the respondents for clarification. Only new out-
comes suggested by two or more participants will be in-
cluded. After removing duplicate responses and
responses that show up only once, all remaining re-
sponses will be grouped into domains. If any new
outcomes cannot be grouped into the existing domains,
new outcome domains will be developed accordingly.
A greater number of outcomes can significantly de-
crease the response rates in a Delphi survey [50]. There-
fore, to reduce attrition and the burden on respondents,
only outcomes that meet the following criteria will be in-
cluded in the second round of the survey: more than
50% of the respondents score between 7 and 9 and less
than 15% score between 1 and 3 [51]. Additional out-
comes suggested by at least 2 participants in round 1 will
also be rated in round 2. On the top of the round 2
questionnaire, the summary results of round 1 will be
fed back to each participant along with their own scor-
ing in round 1. At the end of the round 2 questionnaire,
the participants will be asked to rank their top 10
choices in order of importance [52].
The participants will be divided into two groups—pa-
tients and experts (dental professionals and re-
searchers)—to summarize the rating scores and to
evaluate consensus. The consensus criteria will be con-
sistent with a previous study on COS development [51].
Consensus is divided into consensus in and consensus
out. Consensus in, which means the outcome should be
included in the COS, will be defined as at least 70% of
participants in each group scoring between 7 and 9 and
less than 15% scoring between 1 and 3 for an individual
outcome. Consensus out, which means the outcome
should be excluded from the COS, will be defined as at
least 70% of participants in each group scoring between
1 and 3 and less than 15% scoring between 7 and 9. All
other score distributions will be considered as a lack of
consensus for the inclusion in the COS. Outcomes that
remain undetermined after the 2-round Delphi survey
will be discussed in a consensus meeting for the final
COS-OWSL. In addition, we will analyze how individual
scores change through the Delphi process to show if
participants are moving towards consensus or not.
Phase 4: Consensus meeting
To achieve a final consensus on COS-OWSL, an online
international consensus meeting will be held after the
Delphi survey. A group of key stakeholders will be in-
vited to the meeting to discuss the remaining outcomes
that have not reached a consensus in the Delphi survey,
the definition and terminology of included outcomes,
and the number of outcomes to be included in the final
COS-OWSL. Outcomes that achieve consensus and are
included in the COS-OWSL (consensus in) after the
two-round survey will also be discussed and voted to
confirm their importance.
The key stakeholders attending the consensus meeting
will include representatives of patients, dental profes-
sionals, and researchers. Attendees will be selected
broadly from those who have extensive knowledge or
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experience of orthodontically induced WSLs. From each
group of stakeholders, we will also invite all participants
who have completed both rounds of the Delphi survey
to attend the consensus meeting.
A researcher who does not engage in discussion or
voting will host the online consensus meeting. The re-
sults of the Delphi survey will be presented to all at-
tendees at the consensus meeting. The outcomes that
have not reached consensus in the Delphi survey will be
discussed in detail. The attendees will be asked to offer
their perspectives on the importance of each outcome.
Then, they will vote for each outcome as “in” or “out”
for the inclusion in the final COS-OWSL. Voting will be
conducted anonymously using an online application. A
researcher not involved in the meeting will collect and
analyze all data. Feedback will be provided to the at-
tendees in descriptive statistics after each round of vot-
ing. Consensus will be reached on an outcome when the
majority (>70%) vote as “in” or “out”, and no further vot-
ing of that outcome will be required. Outcomes that do
not achieve a consensus will be further discussed to ex-
plore and resolve divergence. The meeting will alternate
between voting and discussion for three rounds. If no
consensus is achieved in an outcome for three rounds of
discussion and voting, the outcome will not be further
voted and included in the final COS-OWSL. Following
the above process, we will develop the final COS-OWSL
and present the outcomes by appropriate outcome
domains.
Dissemination
The study results will be disseminated through peer-
reviewed academic journals and international confer-
ences. To promote the uptake of the COS-OWSL, we
will engage with relevant groups/organizations such as
the Cochrane Oral Health Group and International As-
sociation for Dental Research. We will also provide all
the participants with a summary of the results.
Discussion
The COS-OWSL study will develop a COS for use in
clinical trials regarding the prevention or treatment of
orthodontically induced WSLs. The development of
COS-OWSL will facilitate and justify the selection of
outcomes and standardize the reporting of results for fu-
ture research. Therefore, the COS-OWSL will help
minimize outcome heterogeneity and reporting bias and
thereby facilitate data syntheses and help reduce avoid-
able research waste [53, 54].
Outcomes used in clinical trials have been chosen
largely by the trialists or academics and are rarely patient
or clinician centered. To identify patient- and dentist-
relevant outcomes, qualitative interviews with patients
and dental professionals will be performed in this study
to ensure no important outcomes are missed. In
addition, we will involve a wide range of key stake-
holders including patients, dental professionals, and re-
searchers in the development of COS-OWSL to collect
different and representative opinions, and thereby de-
velop a commonly accepted COS-OWSL. The final
COS-OWSL will be of adequate clinical relevance and
will be able to help improve dental clinical practice and
patient care.
Study status
The scoping review to identify and summarize the exist-
ing outcomes has been completed.
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